Announcement of The Consolidated Financial Report for The 2nd Quarter of 2021

2021.8.5

Provided by: TTY BIOPHARM COMPANY LIMITED
SEQ_NO 1 Date of announcement 2021/08/05 Time of announcement 14:35:43
Subject Announcement of The Consolidated Financial Report for The 2nd Quarter of 2021
Date of events 2021/08/05 To which item it meets paragraph 31
Statement 1.Date of the financial reports submitted to the board of directors or approved by the board of directors:2021/08/05
2.Date of the financial reports approved by the audit committee:2021/08/05
3.Start and end dates of financial reports of the reporting period:2021/01/01~2021/06/30
4.Operating revenue accumulated from 1/1 to end of the period (thousand NTD):2,007,230
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):1,257,184
6.Net operating income (loss) accumulated from 1/1 to end of the period (thousand NTD):491,217
7.Profit (loss) before tax accumulated from 1/1 to end of the period (thousand NTD):347,658
8.Profit (loss) accumulated from 1/1 to end of the period (thousand NTD):230,880
9.Profit (loss) during the period attributable to owners of parent accumulated from 1/1 to end of the period (thousand NTD):235,023
10.Basic earnings (loss) per share accumulated from 1/1 to end of the period (NTD):0.95
11.Total assets end of the period (thousand NTD):9,523,735
12.Total liabilities end of the period (thousand NTD):3,288,927
13.Equity attributable to owners of parent end of the period (thousand NTD):5,616,437
14.Any other matters that need to be specified:None
TOP